ANTI-GAD AND C-PEPTIDE IN EARLY-ONSET NON-OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR LADA SCREENING. YHCĐ [Internet]. 2026 July 31 [cited 2026 Sept. 9];67(CĐ11-NCKH). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/6038